These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8154340)

  • 1. The effect of recombinant hirudin on arterial thrombosis.
    Wallis RB
    Adv Exp Med Biol; 1993; 340():237-41. PubMed ID: 8154340
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits.
    Rübsamen K; Eschenfelder V
    Haemostasis; 1991; 21 Suppl 1():93-8. PubMed ID: 1894200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of recombinant desulphatohirudin on arterial thrombosis in rats.
    Talbot MD; Ambler J; Butler KD; Lees CM; Mitchell KA; Peters RF; Tweed MF; Wallis RB
    Haemostasis; 1991; 21 Suppl 1():73-9. PubMed ID: 1654294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comeback of the leech. Recombinant hirudin in anti-thrombosis therapy].
    Wildenrath C
    Fortschr Med; 1995 Jan; 113(3):41. PubMed ID: 7890272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study].
    Schiele F; Vuillemenot A; Mouhat T; Kramarz P; Kieffer Y; Camez A; Bassand JP
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):329-35. PubMed ID: 7487286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
    Talbot M
    Semin Thromb Hemost; 1989 Jul; 15(3):293-301. PubMed ID: 2688102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recombinant hirudin and its analogs--new perspectives in antithrombotic treatment].
    Lewandowski K; Zawilska K
    Pol Arch Med Wewn; 1992 Nov; 88(5):273-9. PubMed ID: 1300546
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic effects of recombinant hirudin in different animal models.
    Just M; Tripier D; Seiffge D
    Haemostasis; 1991; 21 Suppl 1():80-7. PubMed ID: 1716605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis model.
    Doutremepuich C; Lalanne MC; Doutremepuich F; Walenga J; Fareed J; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():99-106. PubMed ID: 1894201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

  • 13. Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective.
    Büller HR
    Z Kardiol; 1993; 82 Suppl 2():81-2. PubMed ID: 8328213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
    Raake W; Klauser RJ; Elling H; Zeiller P
    Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH
    Annu Rev Med; 1994; 45():165-77. PubMed ID: 8198374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs.
    Schneider J; Hauser R; Hennies HH; Korioth J; Steffens G; Wnendt S
    Thromb Haemost; 1997 Mar; 77(3):535-9. PubMed ID: 9066007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thrombin in arterial thrombosis: implications for therapy.
    Chesebro JH; Zoldhelyi P; Badimon L; Fuster V
    Thromb Haemost; 1991 Jul; 66(1):1-5. PubMed ID: 1926039
    [No Abstract]   [Full Text] [Related]  

  • 19. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
    Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER
    Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
    Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.